Healthcare expenditures represent a significant share of individual and collective spending in France (11% of GDP in 2009). Despite government efforts to contain these costs, they are expected to grow between 3% and 4% over the next 20 years. This growth is supported by structural factors such as an aging population, the pursuit of well-being and technological progress. These trends create opportunities to develop innovative, high-performing companies capable of answering this growing social need.
Thanks to the industry expertise of a team of Healthcare specialists, we are assisting the development of established players with strong growth potential in areas such as healthcare services (hospitalisation structures, home healthcare and medical analysis). We are also investing in innovative activities such as medical devices, and in niche pharmaceutical laboratories. Finally, we are supporting dynamic, ambitious companies in related activities such as dermo-cosmetics, pharmaceutical development, and services and databases for healthcare organisations. The quality of the teams of executives and entrepreneurs is a key factor in our choice of investments.